Expression and regulation of Cyr61 in human breast cancer cell lines

We have shown that Cyr61, an angiogenic regulator, is overexpressed in invasive and metastatic human breast cancer cells and tumor biopsies. We have further demonstrated that Cyr61 promotes acquisition of estrogen-independence and anti-estrogen resistance in vivo in breast cancer cells. Moreover, we have demonstrated that Cyr61 induces tumor formation and tumor vascularization in vivo, events mediated through the activation of the MAPK and the Akt signaling pathways. Here we investigate how Cyr61 expression is regulated in both estrogen receptor (ER)-positive and ER-negative breast cancer cells. We demonstrate that Cyr61 mRNA and protein expression is inducible by estrogen and anti-estrogens in ER-positive breast cancer cells. We show that a labile protein as well as a negative regulator might be involved in Cyr61 expression in estrogen-dependent breast cancer cells. Other important regulators of Cyr61 expression in breast cancer cells that we found are the phorbol ester TPA, vitamin D, and retinoic acid. TPA causes positive regulation of Cyr61 expression in ER-positive MCF-7 cells. Vitamin D induces a transient stimulatory effect on Cyr61 gene expression. Lastly, retinoic acid has a negative effect on Cyr61 expression and downregulates its expression in MCF-7 cells. Interestingly, most of these effects are not seen in aggressive breast cancer cells that do not express ER and express high levels of Cyr61, such as the MDA-MB-231 cells. Our results are in agreement with our knowledge that Cyr61 promotes tumor growth, and that tumor-promoting agents have a positive impact on cells that express low levels of Cyr61, such as the ER-positive breast cancer cells; however, these agents have no significant effect on cells that express high levels of Cyr61. Our findings suggest an association between increased Cyr61 expression and an aggressive phenotype of breast cancer cells.

[1]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[2]  Y. Nakabeppu,et al.  Genomic response to growth factors. , 1988, Cold Spring Harbor symposia on quantitative biology.

[3]  I. Percival.  Schroedinger's quantum cat , 1991, Nature.

[4]  A. Brunner,et al.  Identification of a gene family regulated by transforming growth factor-beta. , 1991, DNA and cell biology.

[5]  M. Mattei,et al.  Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[6]  H. Herschman,et al.  Glucocorticoid-attenuated Response Genes Encode Intercellular Mediators, Including a New C-X-C Chemokine (*) , 1995, The Journal of Biological Chemistry.

[7]  M. Haussler,et al.  New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. , 1995, Bone.

[8]  R. Lupu,et al.  Involvement of Heregulin-β2 in the Acquisition of the Hormone-independent Phenotype of Breast Cancer Cells , 1996 .

[9]  Gary R. Grotendorst,et al.  Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. , 1996, The Journal of investigative dermatology.

[10]  L. Lau,et al.  Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion , 1996, Molecular and cellular biology.

[11]  T. V. Kolesnikova,et al.  Cyr61, product of a growth factor-inducible immediate-early gene, regulates chondrogenesis in mouse limb bud mesenchymal cells. , 1997, Developmental biology.

[12]  C. Glass,et al.  Nuclear receptor coactivators. , 1997, Current opinion in cell biology.

[13]  T. V. Kolesnikova,et al.  Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. , 1997, Experimental cell research.

[14]  C. Dittrich,et al.  Tyrosine kinase signaling pathways control the expression of retinoic acid receptor-alpha in SK-BR-3 breast cancer cells. , 1997, Cancer letters.

[15]  L. Lau,et al.  Adhesion of Human Umbilical Vein Endothelial Cells to the Immediate-Early Gene Product Cyr61 Is Mediated through Integrin αvβ3 * , 1998, The Journal of Biological Chemistry.

[16]  K. Chung,et al.  Expression of immediate early gene cyr61 during the differentiation of immortalized embryonic hippocampal neuronal cells , 1998, Neuroscience Letters.

[17]  T. V. Kolesnikova,et al.  CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Hüfner,et al.  The Human Analog of Murine Cystein Rich Protein 16 Is a 1α,25-Dihydroxyvitamin D3 Responsive Immediate Early Gene in Human Fetal Osteoblasts: Regulation by Cytokines, Growth Factors, and Serum. , 1998, Endocrinology.

[19]  T. V. Kolesnikova,et al.  Human CYR61-mediated enhancement of bFGF-induced DNA synthesis in human umbilical vein endothelial cells , 1998, Oncogene.

[20]  R. Rivera-Gonzalez,et al.  Estrogen-induced genes in the uterus of ovariectomized rats and their regulation by droloxifene and tamoxifen , 1998, The Journal of Steroid Biochemistry and Molecular Biology.

[21]  D. Mercola,et al.  Differential Effect of Retinoic Acid on Growth Regulation by Phorbol Ester in Human Cancer Cell Lines* , 1999, The Journal of Biological Chemistry.

[22]  Y. Masuho,et al.  Differential regulation of immediate early gene expression in preadipocyte cells through multiple signaling pathways. , 1999, Biochemical and biophysical research communications.

[23]  L. Lau,et al.  Fisp12/Mouse Connective Tissue Growth Factor Mediates Endothelial Cell Adhesion and Migration through Integrin αvβ3, Promotes Endothelial Cell Survival, and Induces Angiogenesis In Vivo , 1999, Molecular and Cellular Biology.

[24]  L. Lau,et al.  Activation-dependent Adhesion of Human Platelets to Cyr61 and Fisp12/Mouse Connective Tissue Growth Factor Is Mediated through Integrin αIIbβ3 * , 1999, The Journal of Biological Chemistry.

[25]  D. Thomas,et al.  An invasion-related complex of cortactin, paxillin and PKCμ associates with invadopodia at sites of extracellular matrix degradation , 1999, Oncogene.

[26]  L. Lau,et al.  The CCN family of angiogenic regulators: the integrin connection. , 1999, Experimental cell research.

[27]  L. Lau,et al.  Adhesion of Human Skin Fibroblasts to Cyr61 Is Mediated through Integrin α6β1 and Cell Surface Heparan Sulfate Proteoglycans* , 2000, The Journal of Biological Chemistry.

[28]  J. Lakins,et al.  Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies. , 2000, Cancer research.

[29]  M. Mayhaus,et al.  Muscarinic Acetylcholine Receptors Induce the Expression of the Immediate Early Growth Regulatory Gene CYR61 * , 2000, The Journal of Biological Chemistry.

[30]  M. Brentani,et al.  Differential regulation of vitamin D receptor expression in distinct leukemic cell lines upon phorbol ester-induced growth arrest. , 2000, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[31]  U. Pendurthi,et al.  Factor VIIa and Thrombin Induce the Expression of Cyr61 and Connective Tissue Growth Factor, Extracellular Matrix Signaling Proteins That Could Act as Possible Downstream Mediators in Factor VIIa·Tissue Factor-induced Signal Transduction* , 2000, The Journal of Biological Chemistry.

[32]  Carl W. Miller,et al.  Breast Cancer , 2001, The Journal of Biological Chemistry.

[33]  R. Winneker,et al.  Cyr61, a Member of the CCN Family, Is Required for MCF-7 Cell Proliferation: Regulation by 17β-Estradiol and Overexpression in Human Breast Cancer. , 2001, Endocrinology.

[34]  L. Lau,et al.  CYR61 Stimulates Human Skin Fibroblast Migration through Integrin αvβ5 and Enhances Mitogenesis through Integrin αvβ3, Independent of Its Carboxyl-terminal Domain* , 2001, The Journal of Biological Chemistry.

[35]  J. Welsh,et al.  Dissociation of vitamin D3 and anti-estrogen mediated growth regulation in MCF-7 breast cancer cells , 1998, Molecular and Cellular Biochemistry.

[36]  T. Grunt,et al.  Involvement of nuclear steroid/thyroid/retinoid receptors and of protein kinases in the regulation of growth and of c‐erbB and retinoic acid receptor expression in MCF‐7 breast cancer cells , 1999, Breast Cancer Research and Treatment.

[37]  M. Brentani,et al.  Vitamin D3 receptor (VDR) expression in HC‐11 mammary cells: regulation by growth‐modulatory agents, differentiation, and Ha‐ras transformation , 1999, Breast Cancer Research and Treatment.